Hepatitis D
📧 Sign up to get email alerts when something new happens for Hepatitis D.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-07-11Clinical Trial Update: Evaluation of the Effectiveness of the Complex of Carnitine Orotate and Biphenyl Dimethyl Dicarboxylate in the Adjuvant Therapy of Chronic Hepatitis D in Real Clinical Practice: a Prospective Cohort Study
A real-world prospective cohort trial evaluating the effectiveness of a complex of carnitine orotate and biphenyl dimethyl dicarboxylate for…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis
A clinical trial is evaluating the long-term effectiveness and clinical outcomes of bulevirtide monotherapy in patients with hepatitis D-rel…
-
CLINICAL_TRIALS research · 2024-05-24Clinical Trial Update: HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV Coinfection
HDV-Europe is an observational study assessing the prevalence and outcomes of hepatitis D in individuals with HIV and hepatitis B co-infecti…
-
CLINICAL_TRIALS trial_result · 2024-04-24Clinical Trial Update: Study of Hepalatide in Chronic Hepatitis D(CHD) Patients [Phase 2]
Phase 2 trial update for Hepalatan in chronic hepatitis D shows completed status; no efficacy results provided in snippet.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection [Phase 3]
A Phase 3 clinical trial evaluating once-daily lonafarnib with ritonavir for chronic hepatitis D virus infection is ongoing, with status cur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Lonafarnib Boosted With Ritonavir With and Without Peginterferon Alfa-2a (PEG IFN-a) in HDV (LOWR-2) [Phase 2]
A Phase 2 trial evaluating lonafarnib with and without ritonavir, with and without peginterferon alfa-2a, in chronic hepatitis D infection h…
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection [Phase 2]
Phase 2 trial evaluating pegylated interferon lambda monotherapy for chronic hepatitis delta virus; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection [Phase 2]
Phase 2 trial investigating P1101 plus TAF with or without UDCA in hepatitis D/HBV co-infected patients; status not disclosed.
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: Lonafarnib With and Without Ritonavir in HDV (LOWR-1) [Phase 2]
Phase 2 trial update evaluating lonafarnib with and without ritonavir in chronic Hepatitis D infection has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon [Phase 2]
Phase 2 trial evaluating lonafarnib, ritonavir, and lambda interferon for chronic hepatitis D has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Myrcludex B in Combination With Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients With Chronic Viral Hepatitis B With Delta-agent [Phase 2]
Phase 2 trial comparing Myrcludex B plus peginterferon alfa-2a versus peginterferon alfa-2a alone in chronic hepatitis B with delta-agent; r…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D [Phase 2]
Phase 2 randomized study evaluating three dosing regimens of Myrcludex B with tenofovir versus tenofovir alone for chronic hepatitis D; stud…
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV) [Phase 2]
Phase 2 study of ARC-520 for chronic hepatitis B with or without other drugs was terminated; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-14Clinical Trial Update: A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D. [Phase 3]
Phase 3 trial update on Pegasys alone or with Tenofovir for chronic hepatitis D has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-24Clinical Trial Update: Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir [Phase 2]
Phase 2 trial update for lonafarnib with ritonavir in chronic hepatitis D completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B [Phase 4]
A Phase 4 trial compares tenofovir alone versus tenofovir plus entecavir in patients with entecavir-resistant chronic hepatitis B and has co…
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infection [Phase 1, Phase 2]
Phase 1/2 trial of Myrcludex B plus pegylated interferon-alpha-2a in HBV/HDV co-infection has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-02-20Clinical Trial Update: Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B [Phase 4]
Phase 4 trial comparing tenofovir plus entecavir versus tenofovir alone in adefovir-resistant chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2018-01-29Clinical Trial Update: HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis [Phase 2]
Phase 2 trial update for HIDIT II evaluating PegIFN-alfa2a plus tenofovir in chronic hepatitis D has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Mother-to-child Hepatitis D Transmission
Update on a completed clinical trial investigating mother-to-child transmission of Hepatitis D.
-
CLINICAL_TRIALS research · 2017-04-07Clinical Trial Update: Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D [Phase 2]
Phase 2 clinical trial evaluating pegylated interferon alone or in combination with ezetimibe for chronic hepatitis D; current status is unk…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Ezetimibe for Patients With Chronic Hepatitis D [Phase 2]
Phase 2 clinical trial update evaluating ezetimibe for chronic hepatitis D; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B [Phase 3]
A Phase 3 trial comparing telbivudine and entecavir in HBeAg-positive chronic hepatitis B completed, evaluating reduction of serum HBsAg lev…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)
An observational trial in Romania assessed how common chronic hepatitis D is and evaluated the efficacy of Pegasys (peginterferon alfa-2a) f…
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Lonafarnib for Chronic Hepatitis D [Phase 2]
Phase 2 trial of lonafarnib for chronic hepatitis D has completed and results were posted on 2016-08-31.